Carle Cancer Center Community Clinical Oncology Program

描述（由申请人提供）：根据RFA CA-03-011社区临床肿瘤项目，伊利诺斯州厄巴纳市卡尔癌症中心国家癌症研究所正在申请继续被指定为伊利诺斯州中东部的CCOP。作为伊利诺伊州第二大私人医疗集团，Carle诊所协会拥有近300名医生，拥有一个全面发展的社区癌症中心项目，自1976年以来一直参与国家临床试验研究。自1983年该项目成立以来，卡尔癌症中心一直作为CCOP获得持续资助。与Carle一起参与此次CCOP申请的机构包括伊利诺伊州乔利埃特的乔利埃特肿瘤血液学协会、伊利诺伊州奥罗拉的拉什-科普利癌症中心和墨西哥墨西哥城的墨西哥国家癌症研究所。联合卡尔癌症中心CCOP为来自伊利诺伊州中东部和印第安纳州西部的38个县，伊利诺伊州芝加哥南部和西南部的4个县以及墨西哥墨西哥城的癌症患者提供服务。CCOP的总部设在卡尔癌症中心，所有的随机化、行政事务和质量保证项目都在伊利诺伊州的厄巴纳管理。CCOPs的主要研究基地是中北部癌症治疗组。与东部肿瘤合作组织和国家乳腺和肠外科辅助项目也有密切的联系。与MD安德森癌症中心的新合作始于2001年。这个

DESCRIPTION (provided by applicant): In response to RFA CA-03-011 Community Clinical Oncology Program, National Cancer institute, the Carle Cancer Center, Urbana, Illinois is making an application to continue to be designated as a CCOP in East Central Illinois. As the second largest private medical group practice in Illinois, with nearly 300 physicians, the Carle Clinic Association has a fully developed community cancer center program, which has been involved in national clinical trials research since 1976. The Carle Cancer Center has been continuously funded as a CCOP since the program's inception in 1983. Joining Carle in this CCOP application as component institutions are the Joliet Oncology Hematology Associates in Joliet, Illinois, Rush-Copley Cancer Center in Aurora, Illinois, and the National Cancer Institute of Mexico in Mexico City, Mexico. The combined Carle Cancer Center CCOP provides services to cancer patients from a large catchment area of 38 counties in east central Illinois and western Indiana, 4 counties south and southwest of Chicago, Illinois and in Mexico City, Mexico. The headquarters for the CCOP is located at the Carle Cancer Center with all randomizations, administrative matters and quality assurance programs managed in Urbana, Illinois. The CCOPs primary research base is the North Central Cancer Treatment Group. There are also strong affiliations with the Eastern Cooperative Oncology Group and the National Surgical Adjuvant Breast and Bowel Project. A new affiliation with the MD Anderson Cancer Center was begun in 2001. The Carle Cancer Center and it's affiliates have dedicated clinical research associates, nurses, and administrative staff to assist 30 investigating medical and radiation oncologists in placing patients and participants on clinical research trials that should result in approximately 135 treatment credits and 210 cancer control credits annually. The goal of the Carle Cancer Center CCOP is to provide progressive state of the art cancer care and prevention to individuals within their own communities. To this end, access and participation in NCI clinical trials of cancer prevention, detection and treatment offer the highest standard of care and the brightest hope for the future.